Literature DB >> 29184003

IL-10 promoter transactivation by the viral K-RTA protein involves the host-cell transcription factors, specificity proteins 1 and 3.

Masanori Miyazawa1, Kohji Noguchi2, Mana Kujirai1, Kazuhiro Katayama1, Satoshi Yamagoe3, Yoshikazu Sugimoto1.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) causes a persistent infection, presenting latent and lytic replication phases during its life cycle. KSHV-related diseases are associated with deregulated expression of inflammatory cytokines, including IL-6 and IL-10, but the mechanisms underlying this dysregulation are unclear. Herein, we report a molecular mechanism for KSHV-induced IL-10 gene expression. KSHV replication and transcription activator (K-RTA) is a molecular switch for the initiation of expression of viral lytic genes, and we describe, for the first time, that K-RTA significantly activates the promoter of the human IL-10 gene. Of note, mutations involving a basic region of K-RTA reduced the association of K-RTA with the IL-10 promoter. Moreover, the host-cell transcription factors, specificity proteins (SP) 1 and 3, play a pivotal cooperative role in K-RTA-mediated transactivation of the IL-10 promoter. K-RTA can interact with SP1 and SP3 directly in vitro, and electrophoresis mobility shift assays (EMSAs) revealed co-operative interaction involving K-RTA, SP1, and SP3 in binding to the IL-10 promoter. As DNase I footprinting assays indicated that K-RTA did not affect SP3 binding to the IL-10 promoter, SP3 can function to recruit K-RTA to the IL-10 promoter. These findings indicate that K-RTA can directly contribute to IL-10 up-regulation via a functional interplay with the cellular transcription factors SP1 and SP3.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  IL-10; SP3; herpesvirus; interleukin; specificity protein 1 (Sp1); transactivation; transcription; viral transcription

Mesh:

Substances:

Year:  2017        PMID: 29184003      PMCID: PMC5767870          DOI: 10.1074/jbc.M117.802900

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Authors:  Yuying Liang; Jean Chang; Stephen J Lynch; David M Lukac; Don Ganem
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

2.  Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Authors:  Diana Palmeri; Kyla Driscoll Carroll; Olga Gonzalez-Lopez; David M Lukac
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 3.  Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.

Authors:  C Boshoff; Y Chang
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

4.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

Review 5.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

Review 6.  Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Authors:  Peter J Murray
Journal:  Curr Opin Pharmacol       Date:  2006-05-18       Impact factor: 5.547

7.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection.

Authors:  P J Murray; L Wang; C Onufryk; R I Tepper; R A Young
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

8.  Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Authors:  Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.

Authors:  Pey-Jium Chang; George Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Authors:  Simon Jochum; Andreas Moosmann; Stephan Lang; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

View more
  3 in total

1.  Viral, immunologic, and clinical features of primary effusion lymphoma.

Authors:  Kathryn Lurain; Mark N Polizzotto; Karen Aleman; Manisha Bhutani; Kathleen M Wyvill; Priscila H Gonçalves; Ramya Ramaswami; Vickie Ann Marshall; Wendell Miley; Seth M Steinberg; Richard F Little; Wyndham Wilson; Armando C Filie; Stefania Pittaluga; Elaine S Jaffe; Denise Whitby; Robert Yarchoan; Thomas S Uldrick
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

Review 2.  Human Virus Transcriptional Regulators.

Authors:  Xing Liu; Ted Hong; Sreeja Parameswaran; Kevin Ernst; Ivan Marazzi; Matthew T Weirauch; Juan I Fuxman Bass
Journal:  Cell       Date:  2020-07-09       Impact factor: 66.850

Review 3.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.